Men on active surveillance for low- to intermediate-risk prostate cancer (PCa) have low risk for PCa-related mortality at a median follow-up of 18 years. However, a majority of men do progress and ...

Results of a study led by VHIO’s Prostate Cancer Group suggest that treatment with CDK4/6 inhibitors followed by senloytic ...

Androgen deprivation therapy (ADT) has long been a foundation in the management of prostate cancer. Since the introduction of ...

City of Hope Research Spotlight offers a glimpse into groundbreaking scientific and clinical discoveries advancing lifesaving ...

King Charles has shared a rare health update as he continues to undergo treatment following his cancer diagnosis.

For older patients with cancer and T2D, GLP-1 RA use is associated with lower all-cause mortality than DPP4i use.

King Charles recently offered a rare personal update on his health during a royal visit, showing signs of recovery more than a year after his cancer diagnosis.

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Anchorage will soon host students from the University of Texas in Austin, but they’re not arriving in the traditional ...

In a significant advancement for prostate cancer research, a first-of-its-kind study led by Emory researchers uncovered how ...

After Teddi Mellencamp shared her cancer had progressed earlier this year, she shared why she has felt “sicker” amid ...